diff --git a/team/_posts/2024-02-01-conti-gabriele.md b/team/_posts/2024-02-01-conti-gabriele.md
new file mode 100644
index 00000000..415e5628
--- /dev/null
+++ b/team/_posts/2024-02-01-conti-gabriele.md
@@ -0,0 +1,23 @@
+---                                                                                                                                                                                                 
+layout: member
+title: Gabriele Conti
+position: Visiting PhD Student
+handle: gconti
+science_names: [G. Conti] 
+image: conti-gabriele.jpg
+alumni: false
+country: [it]
+website: https://www.unibo.it/sitoweb/gabriele.conti12
+ 
+# social
+email: gabriele.conti12@unibo.it
+github: Gabriele-Conti
+orcid: 0000-0002-4623-043X
+linkedin: gabriele-conti-17713417a
+researchgate: Gabriele-Conti-3
+twitter: ContiGabriele96
+---
+
+Gabriele holds BSc and MSc degrees in Biotechnology and Pharmaceutical Biotechnology, respectively, from the Alma Mater Studiorum University of Bologna (Italy), where he is currently a Ph.D. student in the Biotechnological Biocomputational Pharmaceutical Sciences program. His research focuses on the role of the human microbiome in various oncological diseases. Using biocomputational and biostatistical approaches to analyse next-generation sequencing (NGS) microbiome data, his work aims to develop personalised integrated intervention strategies for patients, with a particular focus on haematological malignancies in both adult and paediatric populations.
+  
+During his visiting period at LUMC, Gabriele will focus on a paediatric cohort affected by various haematological malignancies to assess the role of the gut microbiome in allo-HSCT therapy. He will investigate the interaction of the gut microbiome with disease remission and progression, as well as side effects such as aGvHD and febrile neutropenia.